IL-21
Antibodies, Antinuclear
/ immunology
Arthritis, Juvenile
/ immunology
Child
Child, Preschool
Female
Humans
Interferon-gamma
/ metabolism
Interleukin-17
/ metabolism
Interleukins
/ metabolism
Male
Synovial Fluid
/ immunology
T-Lymphocytes, Helper-Inducer
/ immunology
Tumor Necrosis Factor-alpha
/ metabolism
Antinuclear antibodies (ANA)
Cytokine pattern interleukin 21 (IL-21)
Juvenile idiopathic arthritis (JIA)
interleukin 17 (IL-17)
Journal
Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
05
04
2020
revised:
16
05
2020
accepted:
26
05
2020
pubmed:
3
6
2020
medline:
2
2
2021
entrez:
3
6
2020
Statut:
ppublish
Résumé
Juvenile Idiopathic Arthritis (JIA) is currently classified into seven subgroups. Recently, antinuclear antibody (ANA) positive JIA patients were suggested to encompass a clinically homogenous new subgroup. CD4
Identifiants
pubmed: 32485239
pii: S1521-6616(20)30246-1
doi: 10.1016/j.clim.2020.108484
pii:
doi:
Substances chimiques
Antibodies, Antinuclear
0
IFNG protein, human
0
IL17A protein, human
0
Interleukin-17
0
Interleukins
0
TNF protein, human
0
Tumor Necrosis Factor-alpha
0
Interferon-gamma
82115-62-6
interleukin-21
MKM3CA6LT1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
108484Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no conflict of interests.